494 related articles for article (PubMed ID: 22729063)
21. Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT).
Hoff G; Grotmol T; Thiis-Evensen E; Bretthauer M; Gondal G; Vatn MH
Gut; 2004 Sep; 53(9):1329-33. PubMed ID: 15306594
[TBL] [Abstract][Full Text] [Related]
22. Potential impact of population-based colorectal cancer screening in Canada.
Flanagan WM; Le Petit C; Berthelot JM; White KJ; Coombs BA; Jones-McLean E
Chronic Dis Can; 2003; 24(4):81-8. PubMed ID: 14733756
[TBL] [Abstract][Full Text] [Related]
23. An analysis of the duplicate testing strategy of an Irish immunochemical faecal occult blood test colorectal cancer screening programme.
Kelley L; Swan N; Hughes DJ
Colorectal Dis; 2013 Sep; 15(9):e512-21. PubMed ID: 23746062
[TBL] [Abstract][Full Text] [Related]
24. Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom.
UK Colorectal Cancer Screening Pilot Group
BMJ; 2004 Jul; 329(7458):133. PubMed ID: 15237087
[TBL] [Abstract][Full Text] [Related]
25. Limitations of the faecal occult blood test in screening for colorectal cancer.
Delcò F; Sonnenberg A
Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
Tsoi KK; Ng SS; Leung MC; Sung JJ
Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
[TBL] [Abstract][Full Text] [Related]
27. Implementation of colorectal cancer screening in Finland: experiences from the first three years of a public health programme.
Malila N; Oivanen T; Hakama M
Z Gastroenterol; 2008 Apr; 46 Suppl 1():S25-8. PubMed ID: 18368636
[TBL] [Abstract][Full Text] [Related]
28. A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test.
Levi Z; Hazazi R; Rozen P; Vilkin A; Waked A; Niv Y
Aliment Pharmacol Ther; 2006 May; 23(9):1359-64. PubMed ID: 16629942
[TBL] [Abstract][Full Text] [Related]
29. A direct comparison of the prevalence of advanced adenoma and cancer between surveillance and screening colonoscopies.
Crispin A; Mansmann U; Munte A; Op den Winkel M; Göke B; Kolligs FT
Digestion; 2013; 87(3):170-5. PubMed ID: 23635429
[TBL] [Abstract][Full Text] [Related]
30. The effects of promoting colorectal cancer screening on screening utilisation: evaluation of the German Campaign "Aktiv gegen Darmkrebs" (Action against Colorectal Cancer).
Loss J; Eichhorn C; Nagel E
Z Gastroenterol; 2006 Nov; 44(11):1127-34. PubMed ID: 17115353
[TBL] [Abstract][Full Text] [Related]
31. Round one of the Adelaide and Meath Hospital/Trinity College Colorectal Cancer Screening Programme: programme report and analysis based on established international key performance indices.
McNamara D; Qasim A; Lee N; Condon C; O'Morain C
Ir J Med Sci; 2011 Jun; 180(2):549-52. PubMed ID: 21264524
[TBL] [Abstract][Full Text] [Related]
32. Fecal occult blood testing when colonoscopy capacity is limited.
Wilschut JA; Habbema JD; van Leerdam ME; Hol L; Lansdorp-Vogelaar I; Kuipers EJ; van Ballegooijen M
J Natl Cancer Inst; 2011 Dec; 103(23):1741-51. PubMed ID: 22076285
[TBL] [Abstract][Full Text] [Related]
33. Expected reduction of colorectal cancer incidence within 8 years after introduction of the German screening colonoscopy programme: estimates based on 1,875,708 screening colonoscopies.
Brenner H; Hoffmeister M; Brenner G; Altenhofen L; Haug U
Eur J Cancer; 2009 Jul; 45(11):2027-33. PubMed ID: 19289271
[TBL] [Abstract][Full Text] [Related]
34. [Colonoscopic screening in first-degree relatives of patients with sporadic colorectal cancer].
Scintu F; Canalis C; Capra F; D'Alia G; Giordano M; Mocci P; Pisano M; Casula G
Ann Ital Chir; 2000; 71(6):693-9. PubMed ID: 11347322
[TBL] [Abstract][Full Text] [Related]
35. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M;
Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521
[TBL] [Abstract][Full Text] [Related]
36. Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms.
Dancourt V; Lejeune C; Lepage C; Gailliard MC; Meny B; Faivre J
Eur J Cancer; 2008 Oct; 44(15):2254-8. PubMed ID: 18760592
[TBL] [Abstract][Full Text] [Related]
37. Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test.
Denis B; Ruetsch M; Strentz P; Vogel JY; Guth F; Boyaval JM; Pagnon X; Ebelin JF; Gendre I; Perrin P
Gut; 2007 Nov; 56(11):1579-84. PubMed ID: 17616542
[TBL] [Abstract][Full Text] [Related]
38. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population.
Morikawa T; Kato J; Yamaji Y; Wada R; Mitsushima T; Shiratori Y
Gastroenterology; 2005 Aug; 129(2):422-8. PubMed ID: 16083699
[TBL] [Abstract][Full Text] [Related]
39. Screening for colorectal cancer: the cost to find an advanced adenoma.
McGrath JS; Ponich TP; Gregor JC
Am J Gastroenterol; 2002 Nov; 97(11):2902-7. PubMed ID: 12425566
[TBL] [Abstract][Full Text] [Related]
40. Positivity rates and performances of immunochemical faecal occult blood tests at different cut-off levels within a colorectal cancer screening programme.
Faivre J; Dancourt V; Manfredi S; Denis B; Durand G; Gendre I; Bidan JM; Jard C; Levillain R; Jung S; Viguier J; Dorval E
Dig Liver Dis; 2012 Aug; 44(8):700-4. PubMed ID: 22542582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
